Efficacy and biomarker analysis of CD133-directed CAR T cells in advanced hepatocellular carcinoma: a single-arm, open-label, phase II trial

Expressed by cancer stem cells of various epithelial cell origins and hepatocellular carcinoma (HCC), CD133 is an attractive therapeutic target for HCC. The marker CD133 is highly expressed in endothelial progenitor cells (EPC). EPCs circulate in increased numbers in the peripheral blood of patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Dai, Hanren, Tong, Chuan, Shi, Daiwei, Chen, Meixia, Guo, Yelei, Chen, Deyun, Han, Xiao, Wang, Hua, Wang, Yao, Shen, Pingping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7714531/
https://www.ncbi.nlm.nih.gov/pubmed/33312759
http://dx.doi.org/10.1080/2162402X.2020.1846926

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7714531/
https://www.ncbi.nlm.nih.gov/pubmed/33312759
http://dx.doi.org/10.1080/2162402X.2020.1846926

Ejemplares similares